Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Debt (2020 - 2025)

Journey Medical's Total Debt history spans 6 years, with the latest figure at $25.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 1.6% year-over-year to $25.3 million, compared with a TTM value of $25.3 million through Dec 2025, up 1.6%, and an annual FY2025 reading of $25.3 million, up 1.6% over the prior year.
  • Total Debt for Q4 2025 was $25.3 million at Journey Medical, roughly flat from $25.2 million in the prior quarter.
  • The five-year high for Total Debt was $25.3 million in Q4 2025, with the low at $812000.0 in Q4 2021.
  • Average Total Debt over 5 years is $18.4 million, with a median of $19.8 million recorded in 2024.
  • Year-over-year, Total Debt crashed 84.44% in 2021 and then soared 2704.68% in 2022.
  • Tracing DERM's Total Debt over 5 years: stood at $812000.0 in 2021, then soared by 2704.68% to $22.8 million in 2022, then tumbled by 35.8% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then increased by 1.6% to $25.3 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Total Debt are $25.3 million (Q4 2025), $25.2 million (Q3 2025), and $25.1 million (Q2 2025).